EFEK MULTI STRAIN PROBIOTIK TERHADAP KADAR LDL-C Rattus norvegicus HIPERLIPIDEMIA

Kadeq Novita Prajawanti; Jusak Nugraha; Harianto Notopuro; Amellya Octifani; Yohanes Adrian Kapri Negara

doi:10.32382/mak.v14i1.3256

EFEK MULTI STRAIN PROBIOTIK TERHADAP KADAR LDL-C Rattus norvegicus HIPERLIPIDEMIA

Kadeq Novita Prajawanti, Jusak Nugraha, Harianto Notopuro, Amellya Octifani, Yohanes Adrian Kapri Negara

Abstract

Hyperlipidemia is an increase in one or more plasma lipids and the main cause is related to the pattern of food intake. Among the many intestinal microbes, Lactobacillus, Bifidobacterium have been shown to affect the host beneficially by improving the intestinal microbial balance and are therefore categorized as probiotics. The aim of this study was to determine the effect of multi-strain probiotics Lactobacillus rhamnosus and Bifidobacterium bifidum on reducing LDL-C in rat fed HFD 1% per body weight. This True Experimental Research with Pretest-Posttest Design used Rattus norvegicus which was divided into 5 groups each K- (standard feed + tap water), K+ (HFD without probiotics), P1 (HFD + 2mL probiotics), P2 (HFD + 2 .5mL probiotics) and P3 (HFD + 3mL probiotics). The results of the LSD test for LDL cholesterol levels after administration of probiotics, the group that had a significantly different value was in the K- to K+ group with p=0.00; K+ to P1, P2 and P3 with p 0.00 each. Meanwhile, among the treatment groups that were given probiotics, only the P2 to P3 groups showed a significant difference with a p value = 0.037.

Full Text:

PDF (Bahasa Indonesia)

References

Bernini LJ., Simão AC., Alfieri DF., Lozovoy MA., Mari NL., de Souza CH., Dichi I., and Costa GN. 2016. Beneficial effects of Bifidobacterium lactis on lipid profile and cytokines in patients with metabolic syndrome: A randomized trial. Effects of probiotics on metabolic syndrome. Nutrition, 32(6): 716–719.

Divyashri G., Krishna G., Muralidhara, and Prapulla SG. 2015. Probiotic attributes, antioxidant, anti-inflammatory and neuromodulatory effects of Enterococcus faecium CFR 3003: In vitro and in vivo evidence. Journal of Medical Microbiology, 64(12): 1527–1540.

Gadelha CJ., & Bezerra AN. 2019. Effects of probiotics on the lipid profile: Systematic review. Jornal Vascular Brasileiro, 18: 1-10.

Hardisari R., & Putro S. 2018. The Effect of Giving Goat Milk Yoghurt With Lactobacillus Acidophilus and Bifidobacterium To Lipid Fraction Levels in Hyperlipidemic White Rats. Journal of Health Technology, 14(2), 36–40.

Hori M., Imamura T., Narang N., Onoda H., Tanaka S., Ushijima R., Sobajima M., Fukuda N., Ueno H., and Kinugawa K. 2021. Triglyceride and small dense LDL-Cholesterol in patients with acute coronary syndrome. Journal of Clinical Medicine, 10(19): 2-7.

Karam I., Ma N., Liu XW., Li SH., Kong XJ., Li JY., and Yang YJ. 2015. Regulation effect of Aspirin Eugenol Ester on blood lipids in Wistar rats with hyperlipidemia. BMC Veterinary Research, 11(1): 1–7.

Lee IA., Kim DH., Kim KA., Gu W., and Joh EH. 2012. High Fat Diet-Induced Gut Microbiota Exacerbates Inflammation and Obesity in Mice via the TLR4 Signaling Pathway. PLoS ONE, 7(10): 1-11

Liong MT., & Steinbuchel A. 2011. Probiotics: Biology, Genetics and Health Aspects. Heidelberg: Springer.

Ouwehand AC., Invernici MM., Furlaneto FA., and Messora MR. 2018. Effectiveness of Multi-strain Versus Single-strain Probiotics. Journal of Clinical Gastroenterology, 00(00), 1–6.

Rajkumar H., Mahmood N., Kumar M., Varikuti SR., Challa HR., and Myakala SP. 2014. Effect of probiotic (VSL#3) and omega-3 on lipid profile, insulin sensitivity, inflammatory markers, and gut colonization in overweight adults: A randomized, controlled trial. Mediators of Inflammation, 2014:1-8.

Shattat, GF. 2014. A Review Article on Hyperlipidemia : Types , Treatments and New Drug Targets. Biomedical & Pharmacology Journal, 7(2): 399–409.

Skrypnik K., Bogdanski P., Loniewski I., Regula J., & Suliburska J. 2018. Effect of probiotic supplementation on liver function and lipid status in rats. Acta Scientiarum Polonorum, Technologia Alimentaria, 17(2): 185–192.

Sun J., & Buys N. 2015. Effects of probiotics consumption on lowering lipids and CVD risk factors: A systematic review and meta-analysis of randomized controlled trials. Annals of Medicine, 47(6): 430–440.

Wong SK., Chin KY., Suhaimi FH., Fairus A., & Nirwana SI. 2016. Animal Models of Metabolic Syndrome: a review. Nutrition & Metabolism, 13(654): 1–12.

Wu Y., Zhang Q., Ren Y., and Ruan Z. 2017. Effect of probiotic Lactobacillus on lipid profile: A systematic review and meta-analysis of randomized, controlled trials. PLoS ONE, 12(6): 1–15.

DOI: https://doi.org/10.32382/mak.v14i1.3256